SNMMI

SNMMI Elects Cathy Sue Cutler, PhD, FSNMMI, as Vice President-Elect at 2022 Annual Meeting
News | SNMMI
SNMMI elects Cathy Sue Cutler, PhD, FSNMMI, as Vice President-Elect at 2022 Annual Meeting

June 16, 2022 — Cathy Sue Cutler, PhD, FSNMMI, director of the medical isotope research and production program at ...

Time June 16, 2022
arrow
System geometry, imaging mechanism, and performance evaluation of a self-collimating SPECT for fast dynamic cardiac imaging
News | SPECT Imaging
Revolutionary Technology Shortens Cardiac Scan Time, Provides High-quality SPECT Images

June 15, 2022 — A cardiac SPECT imaging system performs scans 10 to 100 times faster than current SPECT systems ...

Time June 15, 2022
arrow
Representative case with acute anterior wall myocardial infarction: Myocardial perfusion images using 99mTc-tetrofosmin at rest (first row), 68Ga-FAPI-46 PET (second row), late gadolinium enhancement (LGE) from cardiac magnetic resonance (third row) and schematic drawings of the left ventricle (fourth row). Area of fibroblast activation exceeds infarct area and LGE signal, most common type of myocardial FAP-distribution. Bottom left: Mean areas of perfusion defect, FAPI-signal and LGE of 35 studied patients
News | PET Imaging
SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling After Heart Attack

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Time June 15, 2022
arrow
Cardiac positron emission tomography (PET) perfusion images for two representative patients. Both patients had similar demographic characteristics. Neither patient had significant perfusion abnormalities as shown in the figure. Patient A had mild sleep apnea while patient B had severe obstructive sleep apnea. The corrected myocardial flow reserve (MFR) for patient A was normal at 3.24 while for patient B it was severely abnormal at 1.22.
News | PET Imaging
PET Imaging Confirms Link Between Obstructive Sleep Apnea and Heart Blood Flow Impairment

June 15, 2022 — Patients with severe obstructive sleep apnea (OSA) are less able to increase blood flow to the heart ...

Time June 15, 2022
arrow
SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting
News | SNMMI
SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting

June 15, 2022 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

Time June 15, 2022
arrow
Heat maps of PSMA PET prostatic fossa recurrence in patients with recurrence limited to the prostate fossa (miTr N0 M0, n=127), pelvic nodal disease (miTr N1 M0, n=30), distant organs/extra-pelvic nodal disease (miTr N0 M1, n=32) and pelvic nodal plus distant organs/extra-pelvic nodal disease (miTr N1 M1, n=37). The yellow contour represents the RTOG CTV
News | Prostate Cancer
PSMA PET Highlights Need for Updated Prostate Cancer Therapy Guidelines

June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of ...

Time June 15, 2022
arrow
Representative axial image from a test set imaging study. From top left to bottom right: CT (A), NAC-PET (B), original AC-PET (C), AI-generated AC-PET (D). The blue arrow indicates one lesion that was observed in both images, and the red arrow indicates a lesion that was missed (i.e., not de-tected by expert nuclear medicine physicians) in AI image. NAC = Non-Attenuation Corrected. AC = Attenuation-Corrected
News | PET-CT
Virtual CT Scans Cut Patient Radiation Exposure in Half During PET/CT Studies

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

Time June 14, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.
News | SNMMI
SNMMI Launches Mars Shot Fund for Nuclear Medicine Research

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot ...

Time June 14, 2022
arrow
SNMMI Elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting
News | SNMMI
SNMMI elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting

June 14, 2022 — Munir Ghesani, MD, FACNM, FACR, chief of nuclear medicine and molecular imaging at Mount Sinai Health ...

Time June 14, 2022
arrow
Offers enhanced SPECT and CT imaging functionalities, including 64-slice CT and automated SPECT motion correction, as well as automated workflow
News | SPECT-CT
Siemens Healthineers Announces FDA Clearance of Symbia Pro.specta SPECT/CT Scanner

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro ...

Time June 13, 2022
arrow
SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences industry that specializes in radiopharmaceuticals, today announced that it will showcase its new Actinium-225 production facility during this year’s annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting being held June 11-14 in Vancouver, British Columbia, Canada.
News | Radiopharmaceuticals and Tracers
SpectronRx to Showcase New Facility for the Global Supply of Actinium-225 at SNMMI 2022

June 13, 2022 — SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences ...

Time June 13, 2022
arrow
At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer
News | Prostate Cancer
GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health and Theranostics for Personalized Prostate Cancer Care

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

Time June 10, 2022
arrow
New Information Statement Addresses How Labs Should Manage Evolving Issues as Pandemic Shifts Toward Chronic Endemic State
News | Coronavirus (COVID-19)
ASNC, IAEA, SNMMI Update COVID-19 Best Practices for Nuclear Cardiology Labs

May 4, 2022 — While the COVID-19 pandemic transitions through various phases, nuclear cardiology teams should maintain a ...

Time May 04, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear Cardiology (ASNC) released a new online course designed to provide cardiovascular and other nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their nuclear imaging laboratories.
News | Nuclear Imaging
New ASNC/SNMMI Training Course Helps Physicians Meet U.S. Requirements for Handling Medical Radioisotopes

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Time April 13, 2022
arrow
Quantitative analysis of pre-treatment PSMA PET/CT in a patient undergoing treatment with ¹⁷⁷Lutetium-PSMA-617/NOX66. Post-treatment PSMA PET/CT demonstrates reduced tumor volume and PSMA intensity. Images created by S Pathmanandavel and L Emmett, St Vincent's Hospital, Sydney, Australia.
News | PET-CT
New Radionuclide Combination Therapy Safe and Effective in Metastatic Prostate Cancer Patients

April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre ...

Time April 11, 2022
arrow
Serial non-contrast axial chest CTs of three study participants with prior COVID-19 pneumonia.
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time March 31, 2022
arrow
With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.
News | Prostate Cancer
SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

Time March 23, 2022
arrow
F-18 FDG PET in COVID-19–related CNS disorders: Principal components analysis of spatial covariance pattern (first row) and statistical parametric mapping analysis of metabolic group differences (second to fifth rows) in patients with COVID-19–related encephalopathy, patients with post-COVID-19 syndrome, and patients with post-COVID-19 syndrome and hyposmia compared to healthy controls (n=13). Image Created by PT Meyer, S Hellwig, G Blazhenets and JA Hosp, Medical Center – University of Freiburg, Germany.
News | Coronavirus (COVID-19)
Molecular Imaging Uncovers Effects of COVID-19 on the Brain

March 23, 2022 — A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive ...

Time March 23, 2022
arrow
Dose tracking software allows hospitals and imaging centers to track levels of radiation used by exam type protocol.
Feature | Radiation Dose Management | By Melinda Taschetta-Millane
Measuring Radiation Dose

Dose tracking software allows hospitals and imaging centers to track levels of radiation used by exam type protocol. It ...

Time March 22, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence.
News | SNMMI
SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence

March 16, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the ...

Time March 16, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now